Tyzeka Trademark Details

Tyzeka was registered on Tuesday, October 31, 2006 and is currently owned by Novartis Ag under the registration number 3164642 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 10 years ago on Friday, June 7, 2013, according to the United State Patent & Trademark Office
Word Mark Tyzeka
Status Dead Registered 710 — Cancelled - Section 8
Serial Number 78533796
Registration Number 3164642
Status Date Friday, June 7, 2013
Filing Date Friday, June 7, 2013
Registration Date Tuesday, October 31, 2006
Attorney Maury M. Tepper, III
Domestic Representative Novartis Pharmaceuticals Corporation

Correspondent

Maury M. Tepper, III
Tepper & Eyster, PLLC
3724 Benson Drive
Raleigh NC 27609

Case File Statements

Goods & Services Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the respiratory system, the musculoskeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in hematology, in oncology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacterial-based disease, antivirals, antibiotics, and antifungals

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, June 7, 2013
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.